Clinical trial
MK0476 Study in Adult Patients With Allergic Rhinitis (0476-378)
NCT00446186 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00446186 |
|---|---|
| Title | MK0476 Study in Adult Patients With Allergic Rhinitis (0476-378) |
| Official title | Mk0476 Phase II Dose Finding Study -Allergic Rhinitis- |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Rhinitis Allergic |
| Intervention type | Drug |
| Interventions | MK0476, montelukast sodium / Duration of Treatment: 2 Weeks, Comparator: placebo / Duration of Treatment: 2 Weeks |
| Enrollment | 945 |
| Start date | Feb 1, 2004 |
| Primary completion | Mar 1, 2004 |
| Completion | Mar 1, 2004 |
| First posted | Mar 12, 2007 |
| Last update posted | Aug 15, 2024 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: